CASE REPORT
Toxic liver disease after intentional paracetamol abuse
for a suicide attempt in a 15-year-old girl
More details
Hide details
Submission date: 2018-04-17
Final revision date: 2018-06-16
Acceptance date: 2018-06-20
Publication date: 2018-08-30
Pediatr Pol 2018;93(4):349-352
KEYWORDS
TOPICS
ABSTRACT
We present a case of a 15-year-old girl who was admitted to hospital due to vomiting, diarrhoea, jaundice, and fever, which were observed for about a week. Liver dysfunction was found in laboratory tests, and the diagnostic process suggested autoimmune hepatitis. Anamnesis and new information from the patient’s family members led to the diagnosis of toxic liver disease after intentional paracetamol abuse for a suicide attempt. There were some essential risk factors: teenage, female sex, serious family troubles. The use of paracetamol for the purpose of suicide is a frequent phenomenon. Because of the increasing number of suicides in teenagers in Poland, it seems to be important to remind to paediatricians about their reasons and risk groups, as well as about clinical and laboratory symptoms of paracetamol poisoning.
REFERENCES (14)
1.
Main Office of Statistics. [Basic information regarding the demographic development of Poland to 2014] (article in Polish). Warsaw 2015.
2.
Mroczkowska-Juchkiewicz A, Krawiec P, Pawłowska-Kamieniak A, et al. Intentional poisonings in urban and rural children – a 6-year retrospective single centre study. Ann Agric Environ Med 2016, 23: 482-486.
3.
Gedeborg R, Svennblad B, Holm L, et al. Increased availability of paracetamol in Sweden and incidence of paracetamol poisoning: using laboratory data to increase validity of a population-based registry study. Pharmacoepidemiol Drug Saf 2017; 26: 518-527.
4.
Sheridan DC, Hendrickson RG, Lin AL, et al. Adolescent Suicidal Ingestion: National Trends Over a Decade. J Adolesc Health 2017; 60: 191-195.
5.
Alvarez F, Berg P, Bianchi F, et al. International Autoimmune Hepatitis Group Report: a review of criteria for the diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929.
6.
Klotz U. Paracetamol (Acetaminophen) – a popular and widely used nonopioid analgesic; Arzneimittelforschung 2012; 62: 355-359.
7.
Kaplowitz N. Acetaminophen hepatoxicity: what do we know, what don’t we know, and what do we do next? Hepatology 2004; 40: 23-26.
8.
Ben-Shachar R, Chen Y, Luo S, et al. The biochemistry of acetaminophen hepatotoxicity and rescue: a mathematical model. Theor Biol Med Model 2012; 9: 5.
9.
Hinson J, Roberts D, James L. Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol 2010; 196: 369-405.
10.
Jóźwiak-Bębenista M, Nowak JZ. Paracetamol: mechanism of action, applications, and safety concern. Acta Pol Pharm 2014; 71: 11-23.
12.
Korzeniowska K, Szałek E, Kaźmierczak E, Jabłecka A. Safety of paracetamol use. Farm Współ 2010; 3: 153-156.
13.
Owsianik D, Mach-Lichota E, Wojtaszek M. [Toxic liver failure in paracetamol poisoned patient abusing ethyl alcohol – case study] (article in Polish). Prz Med Uniw Rzesz Inst Leków 2014; 1: 107-114.
14.
Błaszczak J. [Pharmacokinetics, metabolism and hepatotoxicity of paracetamol after single or combined intoxication with trichloroethylene and N-acetylcysteine]. Doctoral thesis (in Polish). Chair of Toxicology, Poznań University of Medical Sciences, 2011.